|
INTS4L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.422940E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.243800E-03 |
| Normal-vs-Stage2 |
6.455700E-02 |
| Normal-vs-Stage3 |
2.246800E-01 |
| Normal-vs-Stage4 |
8.328600E-01 |
| Stage1-vs-Stage2 |
4.343600E-01 |
| Stage1-vs-Stage3 |
4.080800E-01 |
| Stage1-vs-Stage4 |
3.078600E-01 |
| Stage2-vs-Stage3 |
2.290000E-01 |
| Stage2-vs-Stage4 |
1.413610E-01 |
| Stage3-vs-Stage4 |
5.738800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.037400E-04 |
| Normal-vs-AfricanAmerican |
1.721230E-03 |
| Normal-vs-Asian |
7.135800E-01 |
| Caucasian-vs-AfricanAmerican |
4.450800E-01 |
| Caucasian-vs-Asian |
2.463800E-01 |
| AfricanAmerican-vs-Asian |
1.887170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.391300E-04 |
| Normal-vs-Female |
1.057140E-03 |
| Male-vs-Female |
4.170800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.312600E-01 |
| Normal-vs-Extreme_Weight |
7.556300E-02 |
| Normal-vs-Obese |
3.300100E-03 |
| Normal-vs-Extreme_Obese |
1.222980E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.817400E-01 |
| Normal_Weight-vs-Obese |
1.433380E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.994430E-01 |
| Extreme_Weight-vs-Obese |
2.747600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.530200E-01 |
| Obese-vs-Extreme_Obese |
6.654400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.066600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.785400E-04 |
| Normal-vs-Age(61-80Yrs) |
9.996400E-04 |
| Normal-vs-Age(81-100Yrs) |
9.173000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.935800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.458420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.685200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.115200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.521700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.361620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.27899999999993E-05 |
| Normal-VS-Type2 PRCC |
2.162600E-01 |
| Normal-VS-KIRP CIMP |
2.406200E-01 |
| Normal-VS-Unclassified PRCC |
7.600200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.436800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.642220E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.074400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.278800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.116100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.650960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.997700E-02 |
| Normal-vs-N1 |
1.245980E-01 |
| Normal-vs-N2 |
2.184200E-01 |
| N0-vs-N1 |
8.675600E-01 |
| N0-vs-N2 |
9.052000E-01 |
| N1-vs-N2 |
9.723800E-01 |
|
|
